Observational studyInternational journal of immunopathology and pharmacology

Use of canakinumab and remdesivir in moderate-severe COVID-19 patients: A retrospective analysis.

Antonio Mastroianni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.